Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
Monovalent immune sera against somatic antigens (anti-O) have been shown to potentiate phagocytosis exclusively of nonmucoid homologous immunotypes. To obtain polyvalent immunity for all nonmucoid immunotypes of P. aeruginosa, all immunotypes of these bacteria have to be used for immunization.
Gościniak
G
G
Department of Microbiology, Medical Academy, Wroclaw.
Grzybek-Hryncewicz
K
K
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology; D001426:Bacterial Proteins; D001428:Bacterial Vaccines / Q000032:analysis*; D014644:Genetic Variation; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007110:Immunity, Active; D008074:Lipoproteins / Q000276:immunology*; D008954:Models, Biological; D019081:O Antigens; D010587:Phagocytosis; D054406:Pseudomonas Vaccines; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D011817:Rabbits; D012703:Serotyping; D017778:Vaccines, Combined
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D006023:Glycoproteins; D008074:Lipoproteins; D019081:O Antigens; D054406:Pseudomonas Vaccines; D017778:Vaccines, Combined; C025431:extracellular slime proteins, bacterial; C039987:polyvalent pseudomonas vaccine